Peter Virsik
Direttore operativo presso ESSA PHARMA INC.
Patrimonio netto: 68 826 $ in data 30/04/2024
Posizioni attive di Peter Virsik
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ESSA PHARMA INC. | Direttore operativo | 01/08/2016 | - |
Storia della carriera di Peter Virsik
Precedenti posizioni note di Peter Virsik
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| XENOPORT, INC. | Corporate Officer/Principal | 01/01/2005 | 01/01/2015 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/01/2000 | 01/01/2005 |
Formazione di Peter Virsik
| Kellogg School of Management | Masters Business Admin |
| University of Michigan | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Canada | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Masters Business Admin | 1 |
| Graduate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ESSA PHARMA INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
- Borsa valori
- Insiders
- Peter Virsik
- Esperienza
